AVR Anteris Technologies Global Corp.

6.820USD-3.26%Mkt Cap: 663.87M $P/E: —

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …

Key Statistics

Company
Market Cap663.87M USD
Enterprise Value433.82M USD
Revenue (TTM)2.24M USD
Gross Profit1.34M USD
Net Income (TTM)-94.14M USD
Revenue/Share0.04 USD
Last Price6.820 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees174
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.05
PEG—
EV/EBITDA-4.15
EV/Revenue193.50
P/S306.09
P/B2.73
EPS (TTM)-1.95
EPS (Forward)-1.00
52W Range
3.30045% of range11.05
52W High11.05 USD
52W Low3.300 USD
Profitability
Gross Margin70.26%
Oper. Margin-3072.05%
EBITDA Margin0.00%
Profit Margin-4921.28%
ROE101230.11%
ROA-409.38%
Growth
Revenue Growth63.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.80M USD
CapEx (TTM)1.95M USD
FCF Margin-2280.63%
FCF Yield-7.70%
Net Debt-253.55M USD
Net Debt/EBITDA2.43
Balance Sheet
Debt/Equity-24.54
Current Ratio14.20
Quick Ratio14.02
Book Value/Sh2.58 USD
Cash/Share2.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.33 USD
Upside (mean)+124.8%
Target Range15.00 USD – 16.00 USD
15.00+124.8% to mean16.00
# Analysts3
Ownership
Shares Out.97.34M
Float65.98M
Insiders16.48%
Institutions70.98%
Short Interest
Short Ratio9.9d
Short % Float9.41%
Short % Out.6.59%
Shares Short6.42M
Short (prev mo.)6.93M
Technical
SMA 508.467 (-19.5%)
SMA 2007.262 (-6.1%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)913.73K
Avg Vol (10d)1.03M
Technical Indicators
RSI (14)26.9
MACD-0.3773
MACD Signal-0.2976
MACD Hist.-0.0797
BB Upper8.844 USD
BB Middle7.887 USD
BB Lower6.930 USD
BB Width24.28%
ATR (14)0.3739 USD
Vol Ratio (20d)2.43x